Guangzhou Baiyunshan Phar Hldgs Co Ltd is a pharmaceutical and healthcare group engaged in the research, development, manufacturing, and sales of pharmaceutical products. The company operates across several business segments, including modern traditional Chinese medicine, chemical pharmaceuticals, natural beverages, pharmaceutical commerce, biological innovation, consumer health, and medical services. Its activities cover the wholesale, retail, and import/export of western medicines, traditional Chinese medicines, and medical devices, as well as the provision of hospital medical services and health preservation. The group serves domestic and international markets through its diversified product portfolio and distribution network. It was established in 1997 following the restructuring of eight traditional Chinese medicine manufacturing enterprises and three pharmaceutical trading enterprises under its controlling shareholder, Guangzhou Pharmaceutical Group Co., Ltd.

Summarised from the company's own disclosures, fiscal year ended Apr 2026

Industry Drug Manufacturers - General Homepage gybys.com.cn
Sector Healthcare IR page gybys.com.cn/investment/Investor.html
Tags
traditional chinese medicine, chemical pharmaceuticals, biological products, healthcare services, pharmaceutical distribution, consumer health, medical devices, natural beverages, Guangyao Baiyunshan Hong Kong Company, Guangzhou Hua Cheng Pharmaceutical Factory, Guangdong Yili Pharmaceutical Co. Ltd.
Press page —

Metrics

Valuation  
Market cap HK$ 2.72B
Market cap (USD) $ 346.641M
P/E 6.02
PEG —
P/BV —
P/S —
P/OCF —
P/FCF —
Dividend yield 7.0%
Turnover / mcap 0.49%
Returns  
ROE 7.7%
ROI 5.6%
ROIC 5.7%
Profit margin 3.8%
Growth  
Revenue growing Yes
Profits growing No
Revenue up 3y No
Revenue up 5y No
Earnings growth 3y (net profit CAGR) -9.1%
Quality  
Profitable Yes
Margin expanding No
Buying back stock —
Diluting (TTM) —
Debt/Equity 42.6%
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 0
Quality score 23.1%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2010
Revenue 77.656B 74.993B 75.515B 70.788B 69.014B 61.674B 64.952B 42.234B 20.954B — — — — — — 4.403B
Net profit 2.983B 2.835B 4.056B 3.967B — 3.092B 3.189B 3.441B 2.119B — — — — — — 279.597M

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2010
Share price 16.27 16.59 19.21 20.68 15.67 19.25 32.58 25.86 18.92 — — — — — — —
Price performance 12m 0 -0.13 -0.12 0.26 -0.13 -0.41 0.22 0.34 — — — — — — — —

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

Prompts

Guangzhou Baiyunshan Phar Hldgs Co Ltd (ticker 874), listed in Hong Kong.

ETFs Holding Guangzhou Baiyunshan Phar Hldgs Co Ltd

ETF Weight in ETF Shares Market value As of
DFEV 0.01% 98,000 $ 158.531K Nov 12, 2026
DFSE 0.01% 24,000 $ 38.824K Nov 12, 2026
DFEM 0.00% 268,000 $ 433.534K Nov 12, 2026
DFAE 0.00% 126,000 $ 203.826K Nov 12, 2026
DFAX 0.00% 146,000 $ 236.179K Nov 12, 2026